Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5WIV

Structure of the sodium-bound human D4 Dopamine receptor in complex with Nemonapride

Summary for 5WIV
Entry DOI10.2210/pdb5wiv/pdb
Related5WIU
DescriptorD(4) dopamine receptor, soluble cytochrome b562 chimera, Nemonapride, PHOSPHATE ION, ... (7 entities in total)
Functional Keywordsgpcr, dopamine receptor, antagonist, sodium, signaling protein-antagonist complex, signaling protein/antagonist
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains1
Total formula weight49407.12
Authors
Wacker, D.,Wang, S.,Levit, A.,Che, T.,Betz, R.M.,McCorvy, J.D.,Venkatakrishnan, A.J.,Huang, X.-P.,Dror, R.O.,Shoichet, B.K.,Roth, B.L. (deposition date: 2017-07-20, release date: 2017-10-18, Last modification date: 2024-10-30)
Primary citationWang, S.,Wacker, D.,Levit, A.,Che, T.,Betz, R.M.,McCorvy, J.D.,Venkatakrishnan, A.J.,Huang, X.P.,Dror, R.O.,Shoichet, B.K.,Roth, B.L.
D4 dopamine receptor high-resolution structures enable the discovery of selective agonists.
Science, 358:381-386, 2017
Cited by
PubMed Abstract: Dopamine receptors are implicated in the pathogenesis and treatment of nearly every neuropsychiatric disorder. Although thousands of drugs interact with these receptors, our molecular understanding of dopaminergic drug selectivity and design remains clouded. To illuminate dopamine receptor structure, function, and ligand recognition, we determined crystal structures of the D dopamine receptor in its inactive state bound to the antipsychotic drug nemonapride, with resolutions up to 1.95 angstroms. These structures suggest a mechanism for the control of constitutive signaling, and their unusually high resolution enabled a structure-based campaign for new agonists of the D dopamine receptor. The ability to efficiently exploit structure for specific probe discovery-rapidly moving from elucidating receptor structure to discovering previously unrecognized, selective agonists-testifies to the power of structure-based approaches.
PubMed: 29051383
DOI: 10.1126/science.aan5468
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.143 Å)
Structure validation

231029

數據於2025-02-05公開中

PDB statisticsPDBj update infoContact PDBjnumon